We are live on ! Find out more
DBG

De Burlo Group Portfolio holdings

AUM $441M
1-Year Est. Return 21.21%
This Fund
S&P 500
This Quarter Est. Return
+5.04%
1 Year Est. Return
+21.21%
3 Year Est. Return
+98.05%
5 Year Est. Return
+220.33%
10 Year Est. Return
+1,846.98%
AUM
$411M
AUM Growth
+$50.3M
Cap. Flow
+$49.2M
Cap. Flow %
11.98%
Top 10 Hldgs %
32.14%
Holding
110
New
12
Increased
20
Reduced
51
Closed
15

Top Buys

Rank Stock Value
1
CGNX icon
Cognex
CGNX
+$13.5M
2
C icon
Citigroup
C
+$12.5M
3
SBNY
Signature Bank
SBNY
+$10.2M
4
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$9.99M
5
BNY
Bank of New York Mellon
BNY
+$9.75M

Top Sells

Rank Stock Value
1
TMO icon
Thermo Fisher Scientific
TMO
+$6.46M
2
EW icon
Edwards Lifesciences
EW
+$5.78M
3
CCI icon
Crown Castle
CCI
+$5.48M
4
AVB icon
AvalonBay Communities
AVB
+$5.09M
5
ZBH icon
Zimmer Biomet
ZBH
+$3.44M

Sector Composition

Rank Sector Weight
1 Technology 25.06%
2 Healthcare 18.77%
3 Financials 18.27%
4 Communication Services 9.26%
5 Consumer Discretionary 8.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
V icon
26
Visa
V
$697B
$6.82M 1.66%
87,400
+12,800
+17% +$1.03M
QCOM icon
27
Qualcomm
QCOM
$172B
$6.5M 1.58%
+99,700
New +$6.7M
PG icon
28
Procter & Gamble
PG
$347B
$5.75M 1.4%
68,393
-19,800
-22% -$1.69M
CHD icon
29
Church & Dwight Co
CHD
$23.7B
$5.63M 1.37%
127,300
-25,300
-17% -$1.15M
CMD
30
DELISTED
Cantel Medical Corporation
CMD
$5.53M 1.35%
70,200
+12,400
+21% +$964K
SLB icon
31
SLB Ltd
SLB
$74.2B
$5.25M 1.28%
+62,600
New +$5.13M
SYK icon
32
Stryker
SYK
$133B
$5.16M 1.26%
43,050
-11,600
-21% -$1.33M
ARMK icon
33
Aramark
ARMK
$15.1B
$5.07M 1.23%
196,462
-20,429
-9% -$534K
ABBV icon
34
AbbVie
ABBV
$465B
$5.05M 1.23%
80,650
-41,900
-34% -$2.56M
CIEN icon
35
Ciena
CIEN
$49.6B
$4.8M 1.17%
196,800
-1,900
-1% -$41.5K
ATO icon
36
Atmos Energy
ATO
$29.9B
$4.69M 1.14%
63,300
+1,000
+2% +$72.2K
BCR
37
DELISTED
CR Bard Inc.
BCR
$4.51M 1.1%
20,100
+4,000
+25% +$869K
MAS icon
38
Masco
MAS
$16.5B
$4.32M 1.05%
136,650
-23,250
-15% -$746K
HSIC icon
39
Henry Schein
HSIC
$9.76B
$3.85M 0.94%
64,694
-39,754
-38% -$2.4M
TMO icon
40
Thermo Fisher Scientific
TMO
$214B
$3.7M 0.9%
26,250
-43,800
-63% -$6.46M
INTC icon
41
Intel
INTC
$435B
$3.67M 0.89%
101,041
-13,700
-12% -$491K
T icon
42
AT&T
T
$169B
$3.42M 0.83%
106,578
-31,511
-23% -$930K
GILD icon
43
Gilead Sciences
GILD
$167B
$3.24M 0.79%
45,203
-3,372
-7% -$251K
SBUX icon
44
Starbucks
SBUX
$118B
$3.2M 0.78%
57,600
-5,900
-9% -$327K
ALXN
45
DELISTED
Alexion Pharmaceuticals
ALXN
$3.13M 0.76%
25,614
-2,070
-7% -$253K
OKE icon
46
Oneok
OKE
$55.9B
$3.07M 0.75%
53,450
-3,800
-7% -$199K
NEE icon
47
NextEra Energy
NEE
$186B
$3.05M 0.74%
102,000
-9,200
-8% -$275K
CLB icon
48
Core Laboratories
CLB
$493M
$3.04M 0.74%
+25,300
New +$2.8M
VZ icon
49
Verizon
VZ
$201B
$2.98M 0.73%
55,850
-67,200
-55% -$3.36M
XRAY icon
50
Dentsply Sirona
XRAY
$2.7B
$2.87M 0.7%
49,650
-4,900
-9% -$289K
1
2
3 4 5

Similar funds

ECA
Endeavour Capital Advisors Greenwich, Connecticut $441M AUM 21.38% 1-Year Est. Return
DWML
Decker Wealth Management LLC Nashville, Tennessee $441M AUM
BOA
Birnam Oak Advisors New York $441M AUM 37.12% 1-Year Est. Return
PLU
Performa Ltd (US) Charleston, South Carolina $442M AUM 13.84% 1-Year Est. Return
CPW
Cove Private Wealth Oyster Bay Cove, New York $440M AUM 27.56% 1-Year Est. Return
CAAM
Cape Ann Asset Management London, United Kingdom $440M AUM 96.23% 1-Year Est. Return
SCP
SailingStone Capital Partners Houston, Texas $440M AUM 127.21% 1-Year Est. Return
EFMC
Empire Financial Management Company New York $442M AUM 24.42% 1-Year Est. Return

De Burlo Group's Q4 2016 Portfolio in Review

As of Q4 2016, De Burlo Group held 110 positions worth $411M, up 14% from $360M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

De Burlo Group deployed $49.2M of net new capital in Q4 2016, opening 12 new positions and adding to 20 existing holdings. Its largest new stake was Cognex: 470,800 shares worth $15M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Thermo Fisher Scientific, an estimated $6.46M trimmed.

  • De Burlo Group's largest Q4 2016 buy was Cognex: 470,800 shares worth $15M.
  • De Burlo Group added most to Berkshire Hathaway Class B in Q4 2016, an estimated $9.99M increase.
  • De Burlo Group's biggest Q4 2016 reduction was Thermo Fisher Scientific, cutting an estimated $6.46M.
  • De Burlo Group fully exited AvalonBay Communities in Q4 2016, selling an estimated $5.09M.
  • De Burlo Group's ten largest holdings make up 32% of its $411M portfolio in Q4 2016.
  • De Burlo Group opened 12 new positions and closed 15 in Q4 2016.
  • De Burlo Group's portfolio value rose 14% quarter-over-quarter to $411M.

Based on De Burlo Group's 13F filing for Q4 2016, filed 10 Feb 2017.